MD Start

Our strategic investors

We are fortunate to be backed by institutional investors as well as large medtech players.

In 2019, Sofinnova Partners and MD Start joined forces to launch Sofinnova MD Start III with an initial closing at 48 million euros. Sofinnova MD Start III was fortunate to receive strong support from returning investors Bpifrance, Medtronic, LivaNova, and several new investors including the European Investment Fund (EIF) and Baxter Healthcare Corporation. Additionally, it is supported by a number of world-renowned serial medtech entrepreneurs, all contributing significant resources and expertise.